TNF-alpha Inhibition in CRPS: A Randomized Controlled Trial

Status Withdrawn

Clinical Trial Summary

Studying the effects of Etanercept (an anti-Tumor Necrosis Factor alpha) on early Chronic Regional Pain Syndrome (CRPS). Our hypothesis is that Etanercept will improve patient symptoms if given in early CRPS.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02031211
Study type	Interventional
Source	Stanford University
Contact
Status	Withdrawn
Phase	N/A
Start date	June 2014
Completion date	October 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT00377468` - Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study)	Phase 2
Completed	`NCT01618578` - The Rubber Hand Illusion (RHI) in Patients With CRPS	N/A
Completed	`NCT02467556` - Psychological Intervention and Physiotherapy With Medication Improves CRPS Patients Outcome	Phase 4
Recruiting	`NCT01601925` - Distances From Cricoid Cartilage to the Targets of Stellate Ganglion Block	N/A
Withdrawn	`NCT04709757` - Comparison of Continuous and Burst High Frequency Spinal Cord Stimulation Paradigms	N/A
Completed	`NCT00558753` - Prospective, Randomized Controlled Trial on Perioperative Pregabalin to Reduce Late-onset CRPS After TKA	Phase 2
Active, not recruiting	`NCT05473338` - Complex Regional Pain Syndrome (CRPS) and the Gut-bacteria